In patients with nonalcoholic steatohepatitis, lower levels of adiponectin were associated with higher grades of hepatic steatosis and necroinflammatory activity, suggesting a pathophysiological role for this adipokine in liver disease (11). Here, ADIPOQ is linked to fatty liver disease.